Morning Watch List: Kandi Technolgies (NASDAQ:KNDI), QUALCOMM (NASDAQ:QCOM), Teekay Offshore Partners (NYSE:TOO), Flexion Therapeutics (NASDAQ:FLXN), Avon Products Inc. (NYSE:AVP)

On July 30,2014 Kandi Technologies Group, Inc. (Nasdaq:KNDI), announced that, due to the high demand for EV charging and parking facilities in Hangzhou city, Zhejiang province in China, on-street EV charging/parking stations have been added to the Hangzhou Car-Share Program network to meet the needs of the Car-Share Program participants.  Kandi Technolgies Group, Inc. (NASDAQ:KNDI) belongs to Consumer Goods sector. Its net profit margin is -29.40% and weekly performance is -8.36%. On last trading day company shares ended up $17.21. Kandi Technolgies Group, Inc. (NASDAQ:KNDI) distance from 50-day simple moving average (SMA50) is 11.35%.

QUALCOMM, Inc. (NASDAQ:QCOM) said it donated $325,000 to assist in earthquake relief efforts in China’s Yunnan Province.

Qualcomm has committed the funds to Charities Aid Foundation of America who has made a grant from their fund to the China Youth Development Foundation at the company’s suggestion, Qualcomm said. QUALCOMM, Inc. (NASDAQ:QCOM) shares moved down -0.79% in last trading session and ended the day at $74.14. QCOM Gross Margin is 60.20% and its return on assets is 16.10%. QUALCOMM, Inc. (NASDAQ:QCOM) quarterly performance is -7.27%.

Teekay Offshore Partners L.P. (NYSE:TOO) released its earnings data on Thursday. The company reported $0.17 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.36 by $0.19. On 12 August, Teekay Offshore Partners LP (NYSE:TOO) shares moved down -0.14% and was closed at $34.53. TOO EPS growth in last 5 year was 23.30%. Teekay Offshore Partners LP (NYSE:TOO) year to date (YTD) performance is 9.45%.

Flexion Therapeutics’ (NASDAQ:FLXN) lock-up period will expire on Monday, August 11th. Flexion Therapeutics had issued 5,000,000 shares in its public offering on February 12th. The total size of the offering was $65,000,000 based on an initial share price of $13.00. After the end of the company’s lock-up period, company insiders and major shareholders will be able to sell their shares of the company.Flexion Therapeutics, Inc. (NASDAQ:FLXN) ended the last trading day at $12.96. Company weekly volatility is calculated as 3.00%and price to cash ratio as 2.58. Flexion Therapeutics, Inc. (NASDAQ:FLXN) showed a weekly performance of 3.27%.

Analysts at BMO Capital Markets cut their price target on shares of Avon Products (NYSE:AVP) from $15.00 to $14.00 in a research report issued to clients and investors on Wednesday.Avon Products Inc. (NYSE:AVP) shares moved down -0.22% in last trading session and ended the day on $13.79. AVP Gross Margin is 60.70% and its return on assets is -3.50%. Avon Products Inc. (NYSE:AVP) quarterly performance is 1.85%.